Nisha Pandey

KRAS-Targeted Vaccine Shows Promise In Fighting Pancreatic Cancer, Triggers Strong Immune Response In Early Trial

A new experimental vaccine targeting one of <span>pancreatic <a href="https://www.healthandme.com/health/cancer">cancer</a></span>'s most common genetic mutations has shown encouraging results in an early-stage clinical trial. 

Strong immune responses in most participants were observed, sparking fresh hope against one of the world's deadliest cancers. 

The Phase I study, published in <em><span rel="noindex"><a href="https://www.healthandme.com/health/cancer">Cancer</a></span> Discovery</em>, examined an investigational mutant KRAS-targeted vaccine (mKRAS-VAX) in patients who had undergone surgery for <span>pancreatic ductal adenocarcinoma</span> (PDAC), the most common form of pancreatic cancer. 

The trial enrolled 12 patients with resected KRAS-mutant <a href="https://www.healthandme.com/health-wellness/what-every-breast-cancer-survivor-should-know-after-completing-treatment-article-155094415" data-type="tilCustomLink">pancreatic cancer</a> who received the vaccine alongside two immune checkpoint inhibitors, nivolumab and ipilimumab, after completing standard treatment. 

Researchers observed vaccine-induced T-cell responses in 91.7% of patients, with immune cells remaining detectable for up to two years in some participants. 

Importantly, patients who mounted stronger immune responses also appeared to remain disease-free for longer, although the study was not designed to prove that the vaccine directly improves survival.

Also read: <a href="https://www.healthandme.com/health-news/broadcaster-lauren-laverne-shares-smoldering-myeloma-diagnosis-after-cancer-recovery-article-155118191" data-type="tilCustomLink">Broadcaster Lauren Laverne Shares 'Smoldering Myeloma' Diagnosis After Cancer Recovery</a> 

<h2>Milestone Results Show Strong Immune Response</h2>

According to the researchers, pancreatic cancer has always been difficult to treat because it suppresses immune responses. 

"The significant increase in vaccine-generated T-cell responses demonstrates that the immune system can be trained to recognize KRAS-mutant pancreatic cancer," the researchers said, noting that higher T-cell responses were associated with longer disease-free survival. 

The researchers said that these findings support continued evaluation of <a href="https://www.healthandme.com/health-news/cancer-kills-over-26000-daily-cases-to-hit-35-million-by-2050-says-who-report-article-155011381" data-type="tilCustomLink">KRAS-targeted vaccination</a> strategies in larger clinical trials.

Also read: <a href="https://www.healthandme.com/health-news/postpartum-breast-cancer-may-be-biologically-more-aggressive-heres-why-article-155112076" data-type="tilCustomLink">Postpartum Breast Cancer May Be Biologically More Aggressive; Here’s Why</a> 

<h2>Parallel Research Shows Potential Too</h2>

The promising study follows another recently published Phase I trial in <em>Cancer Discovery </em>that tested a KRAS-targeted vaccine in individuals at high risk of developing pancreatic cancer. 

That study found the vaccine safely stimulated KRAS-specific T-cell responses in about 90% of participants, suggesting such vaccines may eventually help prevent pancreatic cancer in selected high-risk groups. 

Dr. Neeha Zaidi, associate professor of oncology at Johns Hopkins University and one of the corresponding authors of the prevention study, said, "Individuals at high risk due to hereditary predisposition or to the presence of a concerning pancreatic lesion detected on imaging usually undergo surveillance to monitor for changes over time."

Also read: <a href="https://www.healthandme.com/health-wellness/cancer-is-not-a-death-sentence-anymore-how-early-detection-modern-treatment-are-changing-outcomes-in-tier-2-cities-article-155104111" data-type="tilCustomLink">Cancer Is Not A Death Sentence Anymore: How Early Detection &amp; Modern Treatment Are Changing Outcomes In Tier-2 Cities</a> 

She noted that surgery remains the standard treatment when cancer or high-risk lesions are detected, but recurrence remains common, highlighting the need for preventive strategies. 

Elizabeth Jaffee, another author, said, "The goal of this study was to test the safety of the vaccine and induction of durable immune responses." 

She added that the clinical trial was built on existing evidence showing KRAS-targeted vaccination could prevent progression of early precancerous lesions in animal . 

<h2>Importance Of <span rel="noindex">KRAS</span> </h2>

KRAS is one of the most frequently <a href="https://www.healthandme.com/health-wellness/the-new-chapter-after-cancer-focusing-on-wellness-and-quality-of-life-article-154975010" data-type="tilCustomLink">mutated cancer-driving genes</a> in pancreatic cancer, with mutations present in roughly 90% of pancreatic ductal adenocarcinomas. These mutations continuously prompt cancer cells to grow and divide. 

However, scientists have spent decades trying to develop therapies capable of effectively targeting the protein. 

Rather than attacking the cancer directly, the new vaccine teaches the immune system to recognize mutated KRAS proteins as abnormal and launch T-cell attacks against cancer cells.

Cancer Is A Rising Global Threat, Here's Why

Pancreatic cancer remains one of the most aggressive cancers worldwide because symptoms often appear only after the disease has spread beyond the pancreas.

While experts caution that the current findings come from an early-stage study, they say the results provide promising evidence that cancer vaccines can successfully activate the immune system against pancreatic tumors.

Health Conditions A-Z

health

kras-targeted-vaccine-shows-promise-in-fighting-pancreatic-cancer-triggers-strong-immune-response-in-early-trial

pancreatic cancer

kras vaccine

pancreatic ductal adenocarcinoma

kras

Cancer

pancreatic cancer treatment

will-waterborne-diseases-rise-in-the-future-new-study-says-climate-change-could-be-a-major-driver

Will Waterborne Diseases Rise In The Future? New Study Says Climate Change Could Be A Major Driver

mood-swings-anxiety-brain-fog-during-menopause-expert-recommends-looking-beyond-hot-flashes

Mood Swings, Anxiety & Brain Fog During Menopause? Expert Recommends Looking Beyond Hot Flashes

icmr-study-highlights-indias-silent-cholesterol-crisis-9-in-10-adults-have-at-least-one-abnormal-blood-lipid

ICMR Study Highlights India’s Silent Cholesterol Crisis: 9 In 10 Adults Have At Least One Abnormal Blood Lipid

Health News

8 Sit-Up Variations to Strengthen Your Core and Build Stability

Benefits Of Ayurvedic Health Supplement Ashwagandha

9 Anti-Inflammatory Breakfast Options You Should Try

5 Foods You Should Avoid For PCOS, Says Gynecologist

Love Sitting With Your Legs Crossed? Here’s You Should Avoid It

6 Daily Foods That Are Secretly Increasing Your Calories

9 Brain Boosters You Should Do Everyday

Hip Exercises That Will Keep You Flexible As You Age

9 Leg Exercises Office Workers’ Should Do At Home

Benefits of Having Herbal Tea Every Morning

9 Daily Habits That Boost Your Brain Power

Lower-Body Exercises That Are Game-Changers

How Drinking Apple Cider Vinegar Helps You

Aging Myths You Should Never Believe

Superfoods That Support Your Gut Health

What Happens To Your Body When You Eat Instant Noodles Every Day?

Health Issues Premature Babies Often Face

Exercises Office Workers Should Do For Their Heart Health

Reasons Why You Should Add Raw Turmeric To Your Diet

Benefits Of Drinking Milk At Night: Why You Should Do It

Food That Provides Vitamin B12 Naturally In Your Diet

Surprising Health Benefits Of Fenugreek Seeds

9 Superfoods You Should Eat For Your Brain Health

What Does Mental Health Support Look Like At Work?

Long Stretches You Should Do To Unwind From Your Day

Colon Cancer In Young Adults: Early Symptoms You Should Know

Health Benefits Of Eating Dry Fruits Everyday

Are You At Risk For Fried Rice Syndrome?

These Tests Reveal How Well You Are Aging

Lower-Back Exercises You Should Do After A Long-Day's Work

Children’s Diet – What Kids Need To Eat For Immunity Building

Common Diabetes Myths That Could Hurt Your Health

Love Spicy Food? Here’s How It Affects Your Health

Superfood List: Veggies And Fruits You Must Have For Immunity

Foods People With IBS Should Avoid

Exercises To Improve Digestion

Easy Work Lunches You Can Make In The Morning

Hunger Vs Craving: Difference Explained In 60 seconds

These Things Can Cause Your Heart To Age Faster

High Carb Foods That Are Actually Healthy

A new experimental vaccine targeting one of pancreatic cancer's most common genetic mutations has shown encouraging results in an early-stage clinical trial. Strong immune responses in most participants were observed, sparking fresh hope against one of the world's deadliest cancers. About The Study The Phase I study, published in Cancer Discovery, examined an investigational mutant KRAS-targeted vaccine (mKRAS-VAX) in patients who had undergone surgery for pancreatic ductal adenocarcinoma (PDAC), the most common form of pancreatic cancer. The trial enrolled 12 patients with resected KRAS-mutant pancreatic cancer who received the vaccine alongside two immune checkpoint inhibitors, nivolumab and ipilimumab, after completing standard treatment. Researchers observed vaccine-induced T-cell responses in 91.7% of patients, with immune cells remaining detectable for up to two years in some participants. Importantly, patients who mounted stronger immune responses also appeared to remain disease-free for longer, although the study was not designed to prove that the vaccine directly improves survival.Also read: Broadcaster Lauren Laverne Shares 'Smoldering Myeloma' Diagnosis After Cancer Recovery Milestone Results Show Strong Immune ResponseAccording to the researchers, pancreatic cancer has always been difficult to treat because it suppresses immune responses. "The significant increase in vaccine-generated T-cell responses demonstrates that the immune system can be trained to recognize KRAS-mutant pancreatic cancer," the researchers said, noting that higher T-cell responses were associated with longer disease-free survival. The researchers said that these findings support continued evaluation of KRAS-targeted vaccination strategies in larger clinical trials.Also read: Postpartum Breast Cancer May Be Biologically More Aggressive; Here’s Why Parallel Research Shows Potential TooThe promising study follows another recently published Phase I trial in Cancer Discovery that tested a KRAS-targeted vaccine in individuals at high risk of developing pancreatic cancer. That study found the vaccine safely stimulated KRAS-specific T-cell responses in about 90% of participants, suggesting such vaccines may eventually help prevent pancreatic cancer in selected high-risk groups. Dr. Neeha Zaidi, associate professor of oncology at Johns Hopkins University and one of the corresponding authors of the prevention study, said, "Individuals at high risk due to hereditary predisposition or to the presence of a concerning pancreatic lesion detected on imaging usually undergo surveillance to monitor for changes over time."Also read: Cancer Is Not A Death Sentence Anymore: How Early Detection & Modern Treatment Are Changing Outcomes In Tier-2 Cities She noted that surgery remains the standard treatment when cancer or high-risk lesions are detected, but recurrence remains common, highlighting the need for preventive strategies. Elizabeth Jaffee, another author, said, "The goal of this study was to test the safety of the vaccine and induction of durable immune responses." She added that the clinical trial was built on existing evidence showing KRAS-targeted vaccination could prevent progression of early precancerous lesions in animal . Importance Of KRAS KRAS is one of the most frequently mutated cancer-driving genes in pancreatic cancer, with mutations present in roughly 90% of pancreatic ductal adenocarcinomas. These mutations continuously prompt cancer cells to grow and divide. However, scientists have spent decades trying to develop therapies capable of effectively targeting the protein. Rather than attacking the cancer directly, the new vaccine teaches the immune system to recognize mutated KRAS proteins as abnormal and launch T-cell attacks against cancer cells.             Pancreatic cancer remains one of the most aggressive cancers worldwide because symptoms often appear only after the disease has spread beyond the pancreas.While experts caution that the current findings come from an early-stage study, they say the results provide promising evidence that cancer vaccines can successfully activate the immune system against pancreatic tumors.

kras-targeted vaccine shows promise in fighting pancreatic cancer, triggers strong immune response in early trial

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

KRAS-Targeted Vaccine Shows Promise In Fighting Pancreatic Cancer, Triggers Strong Immune Response In Early Trial

Will Waterborne Diseases Rise In The Future? New Study Says Climate Change Could Be A Major Driver

ICMR Study Highlights India’s Silent Cholesterol Crisis: 9 In 10 Adults Have At Least One Abnormal Blood Lipid

As Sonam Wangchuk's Indefinite Fast Continues, Doctors Explain When Hunger Strike Becomes Medically Dangerous

Health Conditions A-Z

Will Waterborne Diseases Rise In The Future? New Study Says Climate Change Could Be A Major Driver

Mood Swings, Anxiety & Brain Fog During Menopause? Expert Recommends Looking Beyond Hot Flashes

ICMR Study Highlights India’s Silent Cholesterol Crisis: 9 In 10 Adults Have At Least One Abnormal Blood Lipid